Website: https://www.generalneuro.com
Twitter: @https://x.com/GeneralNeuroInc
Tweet about this product: Yale-founded @GeneralNeuroInc built NeuroLingo, a brain stimulation headset to improve language and reading development. Now running IRB-approved trials in developmental dyslexia and building toward stroke aphasia rehabilitation. #neurotech #dyslexia #aphasia
NeuroLingo is a non-invasive brain stimulation headset from General Neuro, a Yale-founded neurotechnology company based in Boston. The system delivers transcranial direct current stimulation (tDCS) during active training and rehabilitation to promote faster learning and recovery. The NeuroLingo is currently under clinical testing for improving reading outcomes in developmental dyslexia, with a post-stroke aphasia rehabilitation trial planned for Summer 2027.
